Literature DB >> 19875273

Secure construction of k-unlinkable patient records from distributed providers.

Bradley Malin1.   

Abstract

OBJECTIVES: Healthcare organizations must adopt measures to uphold their patients' right to anonymity when sharing sensitive records, such as DNA sequences, to publicly accessible databanks. This is often achieved by suppressing patient identifiable information; however, such a practice is insufficient because the same organizations may disclose identified patient information, devoid of the sensitive information, for other purposes and patients' organization-visit patterns, or trails, can re-identify records to the identities from which they were derived. There exist various algorithms that healthcare organizations can apply to ascertain when a patient's record is susceptible to trail re-identification, but they require organizations to exchange information regarding the identities of their patients prior to data protection certification. In this paper, we introduce an algorithmic approach to formally thwart trail re-identification in a secure setting. METHODS AND MATERIALS: We present a framework that allows data holders to securely collaborate through a third party. In doing so, healthcare organizations keep all sensitive information in an encrypted state until the third party certifies that the data to be disclosed satisfies a formal data protection model. The model adopted for this work is an extended form of k-unlinkability, a protection model that, until this work, was applied in a non-secure setting only. Given the framework and protection model, we develop an algorithm to generate data that satisfies the protection model. In doing so, we enable healthcare organizations to prevent trail re-identification without revealing identified information.
RESULTS: Theoretically, we prove that the proposed data protection model does not leak information, even in the context of an organization's prior knowledge. Empirically, we use real world hospital discharge records to demonstrate that, while the secure protocol induces additional suppression of patient information in comparison to an existing non-secure approach, the quantity of data disclosed by the secure protocol remains substantial. For instance, in a population of over 7700 sickle cell anemia patients, the non-secure protocol discloses 99.48% of DNA records whereas the secure protocol permits the disclosure of 99.41%.
CONCLUSIONS: Our results demonstrate healthcare organizations can collaborate to disclose significant quantities of personal biomedical data without violating their anonymity in the process. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19875273     DOI: 10.1016/j.artmed.2009.09.002

Source DB:  PubMed          Journal:  Artif Intell Med        ISSN: 0933-3657            Impact factor:   5.326


  4 in total

Review 1.  A review of the role of electronic health record in genomic research.

Authors:  Parasuram Krishnamoorthy; Deepansh Gupta; Saurav Chatterjee; Jessica Huston; John J Ryan
Journal:  J Cardiovasc Transl Res       Date:  2014-08-14       Impact factor: 4.132

2.  An Entropy Approach to Disclosure Risk Assessment: Lessons from Real Applications and Simulated Domains.

Authors:  Edoardo M Airoldi; Xue Bai; Bradley A Malin
Journal:  Decis Support Syst       Date:  2011-04-01       Impact factor: 5.795

3.  A Probabilistic Approach to Mitigate Composition Attacks on Privacy in Non-Coordinated Environments.

Authors:  A H M Sarowar Sattar; Jiuyong Li; Jixue Liu; Raymond Heatherly; Bradley Malin
Journal:  Knowl Based Syst       Date:  2014-09       Impact factor: 8.038

Review 4.  The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future.

Authors:  Omri Gottesman; Helena Kuivaniemi; Gerard Tromp; W Andrew Faucett; Rongling Li; Teri A Manolio; Saskia C Sanderson; Joseph Kannry; Randi Zinberg; Melissa A Basford; Murray Brilliant; David J Carey; Rex L Chisholm; Christopher G Chute; John J Connolly; David Crosslin; Joshua C Denny; Carlos J Gallego; Jonathan L Haines; Hakon Hakonarson; John Harley; Gail P Jarvik; Isaac Kohane; Iftikhar J Kullo; Eric B Larson; Catherine McCarty; Marylyn D Ritchie; Dan M Roden; Maureen E Smith; Erwin P Böttinger; Marc S Williams
Journal:  Genet Med       Date:  2013-06-06       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.